Hot Watch List: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI), FreeSeas Inc. (NASDAQ:FREE), Triple-S Management Corporation (NYSE:GTS), Ophthotech Corporation (NASDAQ:OPHT), Myriad Genetics Inc. (NASDAQ:MYGN)

Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) belongs to Healthcare sector. Its weekly performance is -8.50%. On last trading day company shares ended up $1.40. Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) distance from 50-day simple moving average (SMA50) is -31.96%. On 1 July, Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) said that, Oracle is using Chattanooga’s Rock/Creek for the launch of a new platform called Oracle Commerce Cloud, which aims to take pressure off retailers who want online stores but not the hassle of maintaining them.

FreeSeas Inc. (NASDAQ:FREE) shares moved up 2.62% in last trading session and ended the day at $2.74. FREE return on assets is -53.10%. FreeSeas Inc. (NASDAQ:FREE) quarterly performance is 630.67%. On 25 June, FreeSeas Inc. (NASDAQ:FREE) announced that the Company’s Amended and Restated Articles of Incorporation are being amended to effect a reverse stock split of the Company’s issued and outstanding common stock at a ratio of one new share for every 50 shares currently outstanding.

On 10 July, Triple-S Management Corporation (NYSE:GTS) shares moved up 4.15% and was closed at $22.11. GTS EPS growth in last 5 year was 0.70%. Triple-S Management Corporation (NYSE:GTS) year to date (YTD) performance is -7.53%. Triple-S Management Corporation (NYSE:GTS) announced that it plans to release financial results for the second quarter ended June 30, 2015 before the market opens on Thursday, August 6, 2015.

Ophthotech Corporation (NASDAQ:OPHT) ended the last trading day at $53.92. Company weekly volatility is calculated as 3.18% and price to cash ratio as 4.27. Ophthotech Corporation (NASDAQ:OPHT) showed a weekly performance of 4.03%.Zacks cut shares of Ophthotech Corporation (NASDAQ:OPHT) from a buy rating to a hold rating in a research report sent to investors on Friday morning.

Myriad Genetics Inc. (NASDAQ:MYGN) shares moved up 2.45% in last trading session and ended the day at $34.32. MYGN Gross Margin is 80.60% and its return on assets is 11.90%. Myriad Genetics Inc. (NASDAQ:MYGN) quarterly performance is -3.32%.On 22 June, Myriad Genetics Inc. (NASDAQ:MYGN) said that, it offers innovative tests to determine the genetic basis of human diseases and the role these genes might play in the detection, progression and treatment of specific diseases.

Leave a Reply

Your email address will not be published. Required fields are marked *